| Year |
Citation |
Score |
| 2014 |
Beglinger LJ, Adams WH, Langbehn D, Fiedorowicz JG, Jorge R, Biglan K, Caviness J, Olson B, Robinson RG, Kieburtz K, Paulsen JS. Results of the citalopram to enhance cognition in Huntington disease trial. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 401-5. PMID 24375941 DOI: 10.1002/mds.25750 |
0.31 |
|
| 2013 |
Sieck BC, Smith MM, Duff K, Paulsen JS, Beglinger LJ. Symptom validity test performance in the Huntington Disease Clinic. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. 28: 135-43. PMID 23266566 DOI: 10.1093/Arclin/Acs109 |
0.351 |
|
| 2012 |
Beglinger LJ, Prest L, Mills JA, Paulsen JS, Smith MM, Gonzalez-Alegre P, Rowe KC, Nopoulos P, Uc EY. Clinical predictors of driving status in Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 1146-52. PMID 22744778 DOI: 10.1002/Mds.25101 |
0.352 |
|
| 2011 |
Carlozzi NE, Stout JC, Mills JA, Duff K, Beglinger LJ, Aylward EH, Whitlock KB, Solomon AC, Queller S, Langbehn DR, Johnson SA, Paulsen JS. Estimating premorbid IQ in the prodromal phase of a neurodegenerative disease. The Clinical Neuropsychologist. 25: 757-77. PMID 21660882 DOI: 10.1080/13854046.2011.577811 |
0.316 |
|
| 2011 |
O'Rourke JJ, Beglinger LJ, Smith MM, Mills J, Moser DJ, Rowe KC, Langbehn DR, Duff K, Stout JC, Harrington DL, Carlozzi N, Paulsen JS. The Trail Making Test in prodromal Huntington disease: contributions of disease progression to test performance. Journal of Clinical and Experimental Neuropsychology. 33: 567-79. PMID 21302170 DOI: 10.1080/13803395.2010.541228 |
0.351 |
|
| 2011 |
Stout JC, Paulsen JS, Queller S, Solomon AC, Whitlock KB, Campbell JC, Carlozzi N, Duff K, Beglinger LJ, Langbehn DR, Johnson SA, Biglan KM, Aylward EH. Neurocognitive signs in prodromal Huntington disease. Neuropsychology. 25: 1-14. PMID 20919768 DOI: 10.1037/A0020937 |
0.384 |
|
| 2010 |
Paulsen JS, Wang C, Duff K, Barker R, Nance M, Beglinger L, Moser D, Williams JK, Simpson S, Langbehn D, van Kammen DP. Challenges assessing clinical endpoints in early Huntington disease. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 2595-603. PMID 20623772 DOI: 10.1002/Mds.23337 |
0.399 |
|
| 2010 |
Duff K, Paulsen J, Mills J, Beglinger LJ, Moser DJ, Smith MM, Langbehn D, Stout J, Queller S, Harrington DL. Mild cognitive impairment in prediagnosed Huntington disease. Neurology. 75: 500-7. PMID 20610833 DOI: 10.1212/Wnl.0B013E3181Eccfa2 |
0.395 |
|
| 2010 |
Duff K, Hobson VL, Beglinger LJ, O'Bryant SE. Diagnostic accuracy of the RBANS in mild cognitive impairment: limitations on assessing milder impairments. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. 25: 429-41. PMID 20570820 DOI: 10.1093/Arclin/Acq045 |
0.318 |
|
| 2010 |
Beglinger LJ, O'Rourke JJ, Wang C, Langbehn DR, Duff K, Paulsen JS. Earliest functional declines in Huntington disease. Psychiatry Research. 178: 414-8. PMID 20471695 DOI: 10.1016/J.Psychres.2010.04.030 |
0.353 |
|
| 2010 |
Beglinger LJ, Duff K, Allison J, Theriault D, O'Rourke JJ, Leserman A, Paulsen JS. Cognitive change in patients with Huntington disease on the Repeatable Battery for the Assessment of Neuropsychological Status. Journal of Clinical and Experimental Neuropsychology. 32: 573-8. PMID 19882420 DOI: 10.1080/13803390903313564 |
0.366 |
|
| 2010 |
Duff K, Beglinger LJ, Theriault D, Allison J, Paulsen JS. Cognitive deficits in Huntington's disease on the Repeatable Battery for the Assessment of Neuropsychological Status. Journal of Clinical and Experimental Neuropsychology. 32: 231-8. PMID 19484645 DOI: 10.1080/13803390902926184 |
0.382 |
|
| 2010 |
O'Rourke J, Beglinger L, Mills J, Smith M, Stout J, Queller S, Rao S, Zimbelman J, Paulsen J. Poster 27: Characterizing Psychomotor Declines in Prodromal Huntington Disease with the Trail Making Test Neurotherapeutics. 7: 147-147. DOI: 10.1016/J.Nurt.2009.10.011 |
0.399 |
|
| 2010 |
Adams W, Byars J, O'Rourke J, Flynn A, Fiedorowicz J, Duff K, Leserman A, Nopoulos P, Beglinger L. Poster 26: Word Reading Compared to Demographics-Based Estimates of Premorbid IQ in Early Huntington Disease Neurotherapeutics. 7: 146-147. DOI: 10.1016/J.Nurt.2009.10.010 |
0.388 |
|
| 2010 |
Moser K, Biglan KM, Ross CA, Langbehn DR, Aylward E, Stout JC, Queller S, Carlozzi N, Duff K, Beglinger LJ, Paulsen JS, Tomusk A, Lifer S, Hastings S, Dawson J, ... ... Beglinger L, et al. Inaugural Huntington Disease Clinical Research Symposium Organized by the Huntington Study Group Neurotherapeutics. 5: 202-212. DOI: 10.1016/J.Nurt.2007.10.053 |
0.309 |
|
| 2009 |
ROWE K, BEGLINGER L, WANG C, LANGBEHN D, DUFF K, PAULSEN J. Poster 16: Antidepressant Use in PREDICT-HD: Patterns of Use Relevant to “Naturalistic” Drug Studies Neurotherapeutics. 6: 209-209. DOI: 10.1016/J.Nurt.2008.10.017 |
0.358 |
|
| 2008 |
Beglinger LJ, Paulsen JS, Watson DB, Wang C, Duff K, Langbehn DR, Moser DJ, Paulson HL, Aylward EH, Carlozzi NE, Queller S, Stout JC. Obsessive and compulsive symptoms in prediagnosed Huntington's disease. The Journal of Clinical Psychiatry. 69: 1758-65. PMID 19012814 DOI: 10.4088/Jcp.V69N1111 |
0.333 |
|
| 2008 |
Paulsen JS, Langbehn DR, Stout JC, Aylward E, Ross CA, Nance M, Guttman M, Johnson S, MacDonald M, Beglinger LJ, Duff K, Kayson E, Biglan K, Shoulson I, Oakes D, et al. Detection of Huntington's disease decades before diagnosis: the Predict-HD study. Journal of Neurology, Neurosurgery, and Psychiatry. 79: 874-80. PMID 18096682 DOI: 10.1136/Jnnp.2007.128728 |
0.315 |
|
| Show low-probability matches. |